Business programme 2021
Healthy Life as a Path of Growth: Uniting All, Available to Each
Panel session
The pandemic showed that responsible attitude to personal health is one of the basic values of a healthy society, which must have a high level of solidarity and resistance to the challenges of overwhelming disasters. A state must have sufficient potential so that in a force majeure it would have the resources to provide timely and effective medical care to patients with severe and chronic diseases, including cardiovascular diseases, malignant growths, diseases of the endocrine system, and others. The coronavirus crisis has become a vivid precedent of consolidation of the public and state in each other’s interests. By choosing the path of health protection, the public, on the one hand, helps the state to free up resources to provide up-to-date and high-quality medical care in all areas. On the other hand, the public prompts the creation of an effective infrastructure for healthcare activities, fulfilling the need for healthy living, strengthening of corporate health, and early diagnosis and disease prevention.
● Has the pandemic become an impetus to search for new development vectors in providing care to patients with socially significant diseases? How will the experience of the pandemic be reflected in the quality of such care in the future?
● What healthcare resources should the policy of creating a philosophy of responsible attitude to public health lean on?
● How can the culture of personal health awareness promote changes in present-day algorithms of medical care?
● What new areas in strengthening corporate and public health were created against the background of the pandemic?
● What measures of government policy should promote strengthening of prevention, early diagnosis, and PHC medical care?
● Will awareness of personal health and concomitant disease prevention become an effective measure in preventing the spread of severe diseases and creation of a healthy society?
Oksana Drapkina — Director, National Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian Federation
Vitaliy Omelyanovskiy — General Director, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
Oleg Salagay — Deputy Minister of Health of the Russian Federation
Niels Hessmann — General Director, Bayer; General Representative, Russia and CIS, Bayer AG
Evgeny Shlyakhto — Director General, Almazov National Medical Research Centre; President, All-Russian Non-Governmental Organization "Russian Society of Cardiology"
Yuriy Zhulev — President, Russian Hemophilia Society
Vadim Kukava — Executive Director, The Association of Pharmaceutical Companies «Innovative Pharma»
● Has the pandemic become an impetus to search for new development vectors in providing care to patients with socially significant diseases? How will the experience of the pandemic be reflected in the quality of such care in the future?
● What healthcare resources should the policy of creating a philosophy of responsible attitude to public health lean on?
● How can the culture of personal health awareness promote changes in present-day algorithms of medical care?
● What new areas in strengthening corporate and public health were created against the background of the pandemic?
● What measures of government policy should promote strengthening of prevention, early diagnosis, and PHC medical care?
● Will awareness of personal health and concomitant disease prevention become an effective measure in preventing the spread of severe diseases and creation of a healthy society?
Moderator:
Lika Kremer — Actress, TV-host
Panellists:
Oksana Drapkina — Director, National Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian Federation
Doctor of medical Sciences, Professor, corresponding member of RAS
Oksana M. graduated from the MMA named after I. M. Sechenov in 1992. From 1992 to 1997 she worked in the intensive care unit of the clinic of internal diseases of MMA named after I. M. Sechenov. From 1997 to 2015 she worked at the Department of internal medicine propaedeutics First Moscow State Medical University named after I. M. Sechenov, where she was promoted from Department assistant to Professor. In 2013, she was Awarded the Russian government prize in the field of education. In 2017 she was appointed to the position of Director of "NMRC PM" of the Ministry of health of Russia.
Professor Drapkina combines ongoing clinical work with research activities.
Awards: diploma of the Ministry of health of Russia, Laureate of the Russian Government prize in education, badge " excellence in health care».
There were defended 16 PhD theses and 1 dissertation for the degree of doctor of medical Sciences under the scientific guidance of O. M. Drapkina, more than 600 scientific article were published in domestic and foreign journals, 7 monographs, 10 textbooks
Oksana M. graduated from the MMA named after I. M. Sechenov in 1992. From 1992 to 1997 she worked in the intensive care unit of the clinic of internal diseases of MMA named after I. M. Sechenov. From 1997 to 2015 she worked at the Department of internal medicine propaedeutics First Moscow State Medical University named after I. M. Sechenov, where she was promoted from Department assistant to Professor. In 2013, she was Awarded the Russian government prize in the field of education. In 2017 she was appointed to the position of Director of "NMRC PM" of the Ministry of health of Russia.
Professor Drapkina combines ongoing clinical work with research activities.
Awards: diploma of the Ministry of health of Russia, Laureate of the Russian Government prize in education, badge " excellence in health care».
There were defended 16 PhD theses and 1 dissertation for the degree of doctor of medical Sciences under the scientific guidance of O. M. Drapkina, more than 600 scientific article were published in domestic and foreign journals, 7 monographs, 10 textbooks
Vitaliy Omelyanovskiy — General Director, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
Born July 27, 1964 in Obninsk, Kaluga Oblast.
In 1987, he graduated from the Pirogov Russian National Research Medical University with a degree in General Medicine. After graduation he stayed in the university, where he rose from postgraduate to professor of the department of clinical pharmacology.
In 1998 he graduated from the Russian Presidential Academy of National Economy and Public Administration of the Russian Federation with a degree in state and municipal management, with the qualification of economist-financier.
In 2002, he defended the first doctoral dissertation in the Russian Federation on clinical and economic analysis and pharmacoeconomics.
From 2009 to 2012 he was. - Vladimir Potanin was Director of the Research Institute for Clinical and Economic Expertise and Pharmacoeconomics at the N.I. Pirogov Russian National Research Medical University, Federal State Autonomous Educational Institution of Higher Professional Education, Ministry of Health Care of the Russian Federation.
From 2012 to 2020, she was Head of the Research Laboratory of the N.I. Pirogov Russian National Research Medical University. - Head of the Research Laboratory for Technology Assessment in Healthcare at the Institute of Applied Economic Research of the Russian Presidential Academy of National Economy and Public Administration, a federal state budget-funded educational institution of higher education.
Since 2014. - Head of the Healthcare Finance Center of the Federal State Budgetary Institution "Research Financial Institute" of the Ministry of Finance of the Russian Federation. Ministry of Finance of the Russian Federation.
Since 2015. - General Director of the Federal State Budgetary Institution "Center for Expertise and Quality Control of Medical Care" of the Ministry of Health of the Russian Federation.
Since 2020. - Head of the Department of Economics, Management and Assessment of Healthcare Technologies of the Federal State Budgetary Educational Institution of Additional Professional Education "Russian Medical Academy of Continuing Professional Education" of the Ministry of Healthcare of the Russian Federation.
Member of the Dissertation Council D 208.088.01.
Head of the Expert Council on Health Care of the Federation Council Committee on Social Policy, Expert of the Analytical Centre for the Government of the Russian Federation.
Chief Clinical Pharmacologist, Ministry of Health, Moscow Region.
Chief editor of scientific journals, Pharmacoeconomics. Modern Pharmacoeconomics and Pharmacoepidemiology" and "Medical Technology. Evaluation and Choice".
She is an author of three patents of the Russian Federation, two monographs, educational and methodical manuals for physicians, and more than 140 scientific papers published in Russian and foreign medical journals.
Doctor of Medicine (2002), Professor (2007). Under his supervision V.V. Omelyanovsky defended one doctoral thesis and seven Ph. Currently supervises the theses of two doctoral students and two doctoral candidates.
He is the President of the Russian branch of the International Society for Pharmacoeconomic Research and Outcome Evaluation (ISPOR).
He is a laureate of the Russian Federation Government Award in Science and Technology, has certificates of merit from the President of the Russian Federation and the Chairman of the Federation Council of the Federal Assembly of the Russian Federation, and has received commendations from the Chairman of the Federation Council of the Federal Assembly of the Russian Federation, the Analytical Center of the Russian Federation Government, the Russian Academy of National Economy and Public Administration under the President of the Russian Federation, and the Sverdlovsk Oblast Government.
In 1987, he graduated from the Pirogov Russian National Research Medical University with a degree in General Medicine. After graduation he stayed in the university, where he rose from postgraduate to professor of the department of clinical pharmacology.
In 1998 he graduated from the Russian Presidential Academy of National Economy and Public Administration of the Russian Federation with a degree in state and municipal management, with the qualification of economist-financier.
In 2002, he defended the first doctoral dissertation in the Russian Federation on clinical and economic analysis and pharmacoeconomics.
From 2009 to 2012 he was. - Vladimir Potanin was Director of the Research Institute for Clinical and Economic Expertise and Pharmacoeconomics at the N.I. Pirogov Russian National Research Medical University, Federal State Autonomous Educational Institution of Higher Professional Education, Ministry of Health Care of the Russian Federation.
From 2012 to 2020, she was Head of the Research Laboratory of the N.I. Pirogov Russian National Research Medical University. - Head of the Research Laboratory for Technology Assessment in Healthcare at the Institute of Applied Economic Research of the Russian Presidential Academy of National Economy and Public Administration, a federal state budget-funded educational institution of higher education.
Since 2014. - Head of the Healthcare Finance Center of the Federal State Budgetary Institution "Research Financial Institute" of the Ministry of Finance of the Russian Federation. Ministry of Finance of the Russian Federation.
Since 2015. - General Director of the Federal State Budgetary Institution "Center for Expertise and Quality Control of Medical Care" of the Ministry of Health of the Russian Federation.
Since 2020. - Head of the Department of Economics, Management and Assessment of Healthcare Technologies of the Federal State Budgetary Educational Institution of Additional Professional Education "Russian Medical Academy of Continuing Professional Education" of the Ministry of Healthcare of the Russian Federation.
Member of the Dissertation Council D 208.088.01.
Head of the Expert Council on Health Care of the Federation Council Committee on Social Policy, Expert of the Analytical Centre for the Government of the Russian Federation.
Chief Clinical Pharmacologist, Ministry of Health, Moscow Region.
Chief editor of scientific journals, Pharmacoeconomics. Modern Pharmacoeconomics and Pharmacoepidemiology" and "Medical Technology. Evaluation and Choice".
She is an author of three patents of the Russian Federation, two monographs, educational and methodical manuals for physicians, and more than 140 scientific papers published in Russian and foreign medical journals.
Doctor of Medicine (2002), Professor (2007). Under his supervision V.V. Omelyanovsky defended one doctoral thesis and seven Ph. Currently supervises the theses of two doctoral students and two doctoral candidates.
He is the President of the Russian branch of the International Society for Pharmacoeconomic Research and Outcome Evaluation (ISPOR).
He is a laureate of the Russian Federation Government Award in Science and Technology, has certificates of merit from the President of the Russian Federation and the Chairman of the Federation Council of the Federal Assembly of the Russian Federation, and has received commendations from the Chairman of the Federation Council of the Federal Assembly of the Russian Federation, the Analytical Center of the Russian Federation Government, the Russian Academy of National Economy and Public Administration under the President of the Russian Federation, and the Sverdlovsk Oblast Government.
Oleg Salagay — Deputy Minister of Health of the Russian Federation
Oleg Salagay, Candidate of Medical Sciences, Director of the Department of Public Health and Communications of the Ministry of Healthcare of the Russian Federation, Press Secretary of the Minister of Healthcare of the Russian Federation Veronika Skvortsova.
Born on 3 October 1983 in Irkutsk (Irkutsk Oblast).
In 2005, graduated with honours from Irkutsk State Medical University.
In 2006, graduated with honours from the Academy of Labour and Social Relations, Department of Law.
In 2010, graduated with honours from the Diplomatic Academy of Russian Foreign Ministry.
In 2011, received a Master’s Degree in European Law from Moscow State Institute of International Relations (MGIMO University) under the Ministry of Foreign Affairs of the Russian Federation.
Oleg Salagay is a member of many working groups under the auspices of the World Health Organization, BRICS, and bilateral cooperation. He is Chairman of the Conference of the Parties to the Framework Convention on Tobacco Control.
Born on 3 October 1983 in Irkutsk (Irkutsk Oblast).
In 2005, graduated with honours from Irkutsk State Medical University.
In 2006, graduated with honours from the Academy of Labour and Social Relations, Department of Law.
In 2010, graduated with honours from the Diplomatic Academy of Russian Foreign Ministry.
In 2011, received a Master’s Degree in European Law from Moscow State Institute of International Relations (MGIMO University) under the Ministry of Foreign Affairs of the Russian Federation.
Oleg Salagay is a member of many working groups under the auspices of the World Health Organization, BRICS, and bilateral cooperation. He is Chairman of the Conference of the Parties to the Framework Convention on Tobacco Control.
Niels Hessmann — General Director, Bayer; General Representative, Russia and CIS, Bayer AG
Niels Hessmann is the Managing Director of Bayer JSC and Senior Bayer Representative in Russia and CIS since March 1, 2015.
Niels Hessmann was born in Belgium and studied applied economic sciences at the University of Antwerp, Belgium. He began his career as a Market Research Manager in Schering (now Bayer) in Belgium in 1992.
In 1996, he headed the Marketing and Sales Department of Schering Romania and Moldova.
In 1999, he became the Managing Director of Schering Kazakhstan and was responsible for the company development in Central Asia.
In 2001, he was appointed the Managing Director of Schering Greece. In 2007, he headed Bayer Netherlands and was Bayer Healthcare Representative. During that period, Mr. Hessmann was also responsible for merging Bayer and Schering.
From November 2011 to February 2015, he was the Managing Director and Country Division Head Bayer HealthCare in South-Korea.
Niels Hessmann was born in Belgium and studied applied economic sciences at the University of Antwerp, Belgium. He began his career as a Market Research Manager in Schering (now Bayer) in Belgium in 1992.
In 1996, he headed the Marketing and Sales Department of Schering Romania and Moldova.
In 1999, he became the Managing Director of Schering Kazakhstan and was responsible for the company development in Central Asia.
In 2001, he was appointed the Managing Director of Schering Greece. In 2007, he headed Bayer Netherlands and was Bayer Healthcare Representative. During that period, Mr. Hessmann was also responsible for merging Bayer and Schering.
From November 2011 to February 2015, he was the Managing Director and Country Division Head Bayer HealthCare in South-Korea.
Evgeny Shlyakhto — Director General, Almazov National Medical Research Centre; President, All-Russian Non-Governmental Organization "Russian Society of Cardiology"
Professor Evgeny Shlyakhto, Director General of the Almazov National Medical Research Centre, Academician of the Russian Academy of Science, President of the Russian Society of Cardiology, Fellow of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology.
Professor Shlyakhto was born on June 29, 1954 in Pogar, the Bryansk region. He graduated from the Pavlov Medical University in Saint Petersburg in 1977 and became Doctor of Science in Medicine in 1992, Professor in 1994, Honored Russian Scientist in 2004, and Academician of the Russian Academy of Sciences in 2014.
Evgeny Shlyakhto has been the Director General of the Almazov National Medical Research Centre since 2001 and the President of the Russian Society of Cardiology since 2011. In 2010, he became a member of the WHO Expert Working Group.
The Centre led by Prof. Shlyakhto carries out intensive research in the fields of translational medicine, molecular diagnostics, development of diagnostic tools for personalized treatment, cellular and tissue engineering for therapeutic purposes, creation of biocompatible materials and tissue-engineered constructs designed to create breakthrough medical technologies of fundamental importance for providing high-tech care to patients with cardiovascular, endocrine and blood diseases.
The results of research work by Prof. Shlyakhto have been summarized in more than 800 publications, 16 inventions, 2 scientific discoveries, and a number of monographs. Prof. Shlyakhto was a supervisor in 57 PhD and 20 DSc students..
Professor Shlyakhto is a member of the Presidium of the Russian Academy of Science, the Presidential Council for Science and Education, the Regional Health Council under the Federation Council of the Russian Federal Assembly, the Expert Health Council of the Federation Council Committee on Social Policy of the Russian Federal Assembly, Vice President of the National Medical Chamber.
Evgeny Shlyakhto is the Editor-in-Chief of the following medical journals: Russian Journal of Cardiology, Translational Medicine, and Journal of Arrhythmology. He also is a member of the international editorial board of the European Heart Journal.
Professor Shlyakhto plays an active role in such international committees as the ESC Congress Programme Committee (since 2012) and of the ESC Committee for Practice Guidelines (since 2015).
Evgeny Shlyakhto received the Russian Federation Government Prize in science and technology in 2009 and won the Pavlov Award, the prize for scientific and technological achievement in Physiology and Medicine from the Saint Petersburg Government and St. Petersburg Scientific Center of the Russian Academy of Sciences, in 2011. He received an Order of Honour in 2012 and 4th class Order of Merit for the Motherland in 2017.
Professor Shlyakhto was born on June 29, 1954 in Pogar, the Bryansk region. He graduated from the Pavlov Medical University in Saint Petersburg in 1977 and became Doctor of Science in Medicine in 1992, Professor in 1994, Honored Russian Scientist in 2004, and Academician of the Russian Academy of Sciences in 2014.
Evgeny Shlyakhto has been the Director General of the Almazov National Medical Research Centre since 2001 and the President of the Russian Society of Cardiology since 2011. In 2010, he became a member of the WHO Expert Working Group.
The Centre led by Prof. Shlyakhto carries out intensive research in the fields of translational medicine, molecular diagnostics, development of diagnostic tools for personalized treatment, cellular and tissue engineering for therapeutic purposes, creation of biocompatible materials and tissue-engineered constructs designed to create breakthrough medical technologies of fundamental importance for providing high-tech care to patients with cardiovascular, endocrine and blood diseases.
The results of research work by Prof. Shlyakhto have been summarized in more than 800 publications, 16 inventions, 2 scientific discoveries, and a number of monographs. Prof. Shlyakhto was a supervisor in 57 PhD and 20 DSc students..
Professor Shlyakhto is a member of the Presidium of the Russian Academy of Science, the Presidential Council for Science and Education, the Regional Health Council under the Federation Council of the Russian Federal Assembly, the Expert Health Council of the Federation Council Committee on Social Policy of the Russian Federal Assembly, Vice President of the National Medical Chamber.
Evgeny Shlyakhto is the Editor-in-Chief of the following medical journals: Russian Journal of Cardiology, Translational Medicine, and Journal of Arrhythmology. He also is a member of the international editorial board of the European Heart Journal.
Professor Shlyakhto plays an active role in such international committees as the ESC Congress Programme Committee (since 2012) and of the ESC Committee for Practice Guidelines (since 2015).
Evgeny Shlyakhto received the Russian Federation Government Prize in science and technology in 2009 and won the Pavlov Award, the prize for scientific and technological achievement in Physiology and Medicine from the Saint Petersburg Government and St. Petersburg Scientific Center of the Russian Academy of Sciences, in 2011. He received an Order of Honour in 2012 and 4th class Order of Merit for the Motherland in 2017.
Front row participants:
Yuriy Zhulev — President, Russian Hemophilia Society
In 1985, graduated from the school number 856 (Moscow).
In 1991, graduated from the Moscow State Law University.
In 1989, he was elected Vice President of Hemophilia Association (later renamed Hemophilia Society) that was established the same year.
Since 1993, he was the President of the Hemophilia Society.
In 2000, at the founding congress of the Russian Hemophilia Society he was elected its President, and he still holds this position.
In 2002–2004, he was a board member of the European Hemophilia Consortium and member of the World Federation of Hemophilia. He was named ‘Best volunteer’ of the World Federation of Hemophilia for his active work in CIS countries.
At present, he also holds the following positions:
• Co-chairman of the Russian Union of Patients Public Societies;
• Member of Commission for the Disabled under President of the Russian Federation;
• Head of the working group for improvement of the state sociomedical assessment system and monitoring of implementation of decisions made for the Commission for the Disabled under President of the Russian Federation;
• Co-chair of the Council of public agencies for patients’ rights for the Ministry of Health of the Russian Federation;
• Deputy Chairman of the Public Council of the Ministry of Health of the Russian Federation;
• Member of Council of public agencies for patients’ rights for Federal Service for Surveillance in Healthcare;
• Member of Moscow’s regional department of All-Russia People's Front.
Yury Zhulyov was awarded with an honorary certificate by the Ministry of Health of the Russian Federation, an honorary certificate by the Federal Service for Surveillance in Healthcare and Social Development.
In 1991, graduated from the Moscow State Law University.
In 1989, he was elected Vice President of Hemophilia Association (later renamed Hemophilia Society) that was established the same year.
Since 1993, he was the President of the Hemophilia Society.
In 2000, at the founding congress of the Russian Hemophilia Society he was elected its President, and he still holds this position.
In 2002–2004, he was a board member of the European Hemophilia Consortium and member of the World Federation of Hemophilia. He was named ‘Best volunteer’ of the World Federation of Hemophilia for his active work in CIS countries.
At present, he also holds the following positions:
• Co-chairman of the Russian Union of Patients Public Societies;
• Member of Commission for the Disabled under President of the Russian Federation;
• Head of the working group for improvement of the state sociomedical assessment system and monitoring of implementation of decisions made for the Commission for the Disabled under President of the Russian Federation;
• Co-chair of the Council of public agencies for patients’ rights for the Ministry of Health of the Russian Federation;
• Deputy Chairman of the Public Council of the Ministry of Health of the Russian Federation;
• Member of Council of public agencies for patients’ rights for Federal Service for Surveillance in Healthcare;
• Member of Moscow’s regional department of All-Russia People's Front.
Yury Zhulyov was awarded with an honorary certificate by the Ministry of Health of the Russian Federation, an honorary certificate by the Federal Service for Surveillance in Healthcare and Social Development.
Vadim Kukava — Executive Director, The Association of Pharmaceutical Companies «Innovative Pharma»
In 2012, Vadim Kukava was offered the position of Executive Director of the Association of leading global innovative pharmaceutical companies, InPharma. During this time, the Association has become a key player in the Russian pharmaceutical market, collaborating with government bodies to develop balanced regulations of the industry for the benefit of Russian patents.
From 2006 to 2012, Vadim worked in leading international companies that produce consumer goods, in positions connected to public/GR relations and policy affairs. During this time, Vadim participated in discussions on key legislation in the sphere of regulating the tobacco and medical industries, collaborated with representatives of the Russian and European scientific communities, and played an active role in the work of industrial associations, including on the Board. In addition, Vadim was responsible for creating and developing a division for public and regulatory affairs.
From 2004 to 2006, he worked as a consultant at the Federal Agency for State Property Administration (Rosimuschestvo). Vadim was responsible for implementing the full range of powers of ownership related to property within the forestry and chemical industry owned by the Russian Federation.
In 2003, he graduated from the Faculty of Law of the International University in Moscow.
From 2006 to 2012, Vadim worked in leading international companies that produce consumer goods, in positions connected to public/GR relations and policy affairs. During this time, Vadim participated in discussions on key legislation in the sphere of regulating the tobacco and medical industries, collaborated with representatives of the Russian and European scientific communities, and played an active role in the work of industrial associations, including on the Board. In addition, Vadim was responsible for creating and developing a division for public and regulatory affairs.
From 2004 to 2006, he worked as a consultant at the Federal Agency for State Property Administration (Rosimuschestvo). Vadim was responsible for implementing the full range of powers of ownership related to property within the forestry and chemical industry owned by the Russian Federation.
In 2003, he graduated from the Faculty of Law of the International University in Moscow.
Present-Day Therapy Against Diabetes: Innovations for Improving the Quality of Life
Panel session
The critical growth rate of diabetes and high risks of complications leading to disability and premature death require taking significant measures at the state level. One of the key objectives is ensuring that innovative treatment is available to the patients. Today, innovative sugar-lowering combination drugs are as revolutionary in treating type 2 diabetes as insulin was a hundred years ago. The issues of technological development, support and stimulus of research and development, clinical research and inclusion of new treatment schemas in clinical recommendations, and improvement of availability of modern drugs are quite critical and require federal support. Ensuring quick access to innovative treatment by the public is, among others, a matter of drug supply financing, expanding lists of benefits, creating patient registers, etc. In the long run, such measures will lead the practice of innovative drug supply to principles of individual approach to each diabetes patient.
● What steps need to be taken for innovative diabetes drugs to be produced in Russia in sufficient quantities?
● What needs to be done for patients to have access to modern drugs manufactured on international markets?
● What mechanisms and regulatory initiatives can stimulate the pharma industry to manufacture innovative drugs?
● What measures can promote increased availability of modern treatment?
● Will resuming the federal diabetes programme promote the goal of providing citizens with innovative treatment and in what way?
Elena Voytsekhovskaya — Anchor, Doctor Channel
Elena Astapenko — Director, Department of Pharmaceutical Provision and Regulation of the Circulation of Medical Devices, Ministry of Health of the Russian Federation
(online)
Hans Duijf — Vice-President, Russia and Belarus, Novo Nordisk
Yuriy Zhulev — President, Russian Hemophilia Society
● What steps need to be taken for innovative diabetes drugs to be produced in Russia in sufficient quantities?
● What needs to be done for patients to have access to modern drugs manufactured on international markets?
● What mechanisms and regulatory initiatives can stimulate the pharma industry to manufacture innovative drugs?
● What measures can promote increased availability of modern treatment?
● Will resuming the federal diabetes programme promote the goal of providing citizens with innovative treatment and in what way?
Moderator:
Elena Voytsekhovskaya — Anchor, Doctor Channel
Panellists:
Alexander Ametov — Head of Sub-department of Endocrinology of the Russian Medical Academy of Continuing Professional Education under the Ministry of Health of Russia
Elena Astapenko — Director, Department of Pharmaceutical Provision and Regulation of the Circulation of Medical Devices, Ministry of Health of the Russian Federation
(online)
Dmitriy Galkin — Director of Department of Pharmaceutical and Medical Industry Development, Ministry of Industry and Trade of the Russian Federation
(online)
Hans Duijf — Vice-President, Russia and Belarus, Novo Nordisk
Hans Duijf was appointed Vice President of Novo Nordisk in Russia and Belarus since September 1, 2017.
Mr. Duijf is a Dutch national, born in June 1974. He moved to Moscow with his family, wife and two daughters, from Colombia, where he held the position of General Manager of the Novo Nordisk affiliate since 2015.
Mr. Duijf has nearly 20 years of experience in the affiliates and regional headquarters of Novo Nordisk in established and developing markets in Europe, South-East Asia and Latin America. Under his leadership diverse teams of different cultures consistently succeeded in improving performance and introducing innovative approaches. Mr. Duijf began his career in sales and marketing in the UK, and later participated in the product launching in the markets of different countries. He has extensive management experience in positions such as Marketing Director, Business Development Director, General Manager, Vice President.
Hans Duijf has received education in international marketing and strategic management and holds a Master of Science (M.Sc.) degree in Business Administration from Rotterdam School of Management, Erasmus University in the Netherlands.
Mr. Duijf is a Dutch national, born in June 1974. He moved to Moscow with his family, wife and two daughters, from Colombia, where he held the position of General Manager of the Novo Nordisk affiliate since 2015.
Mr. Duijf has nearly 20 years of experience in the affiliates and regional headquarters of Novo Nordisk in established and developing markets in Europe, South-East Asia and Latin America. Under his leadership diverse teams of different cultures consistently succeeded in improving performance and introducing innovative approaches. Mr. Duijf began his career in sales and marketing in the UK, and later participated in the product launching in the markets of different countries. He has extensive management experience in positions such as Marketing Director, Business Development Director, General Manager, Vice President.
Hans Duijf has received education in international marketing and strategic management and holds a Master of Science (M.Sc.) degree in Business Administration from Rotterdam School of Management, Erasmus University in the Netherlands.
Yuriy Zhulev — President, Russian Hemophilia Society
In 1985, graduated from the school number 856 (Moscow).
In 1991, graduated from the Moscow State Law University.
In 1989, he was elected Vice President of Hemophilia Association (later renamed Hemophilia Society) that was established the same year.
Since 1993, he was the President of the Hemophilia Society.
In 2000, at the founding congress of the Russian Hemophilia Society he was elected its President, and he still holds this position.
In 2002–2004, he was a board member of the European Hemophilia Consortium and member of the World Federation of Hemophilia. He was named ‘Best volunteer’ of the World Federation of Hemophilia for his active work in CIS countries.
At present, he also holds the following positions:
• Co-chairman of the Russian Union of Patients Public Societies;
• Member of Commission for the Disabled under President of the Russian Federation;
• Head of the working group for improvement of the state sociomedical assessment system and monitoring of implementation of decisions made for the Commission for the Disabled under President of the Russian Federation;
• Co-chair of the Council of public agencies for patients’ rights for the Ministry of Health of the Russian Federation;
• Deputy Chairman of the Public Council of the Ministry of Health of the Russian Federation;
• Member of Council of public agencies for patients’ rights for Federal Service for Surveillance in Healthcare;
• Member of Moscow’s regional department of All-Russia People's Front.
Yury Zhulyov was awarded with an honorary certificate by the Ministry of Health of the Russian Federation, an honorary certificate by the Federal Service for Surveillance in Healthcare and Social Development.
In 1991, graduated from the Moscow State Law University.
In 1989, he was elected Vice President of Hemophilia Association (later renamed Hemophilia Society) that was established the same year.
Since 1993, he was the President of the Hemophilia Society.
In 2000, at the founding congress of the Russian Hemophilia Society he was elected its President, and he still holds this position.
In 2002–2004, he was a board member of the European Hemophilia Consortium and member of the World Federation of Hemophilia. He was named ‘Best volunteer’ of the World Federation of Hemophilia for his active work in CIS countries.
At present, he also holds the following positions:
• Co-chairman of the Russian Union of Patients Public Societies;
• Member of Commission for the Disabled under President of the Russian Federation;
• Head of the working group for improvement of the state sociomedical assessment system and monitoring of implementation of decisions made for the Commission for the Disabled under President of the Russian Federation;
• Co-chair of the Council of public agencies for patients’ rights for the Ministry of Health of the Russian Federation;
• Deputy Chairman of the Public Council of the Ministry of Health of the Russian Federation;
• Member of Council of public agencies for patients’ rights for Federal Service for Surveillance in Healthcare;
• Member of Moscow’s regional department of All-Russia People's Front.
Yury Zhulyov was awarded with an honorary certificate by the Ministry of Health of the Russian Federation, an honorary certificate by the Federal Service for Surveillance in Healthcare and Social Development.
Natalia Rudovich — Ассоциированный профессор, Медицинский Университет Цюриха; глава эндокринологического и диабетического подразделения департамента международной медицины, Больница Бюлах; член международного консультативного комитета, ФГБУ «Национальный медицинский исследовательский центр имени В.А. Алмазова» Минздрава России
(online)
Oleg Ergashev — Vice-Governor of Saint Petersburg
Medical Science. How to Expedite Introduction into Practical Healthcare
Panel session
Session sponsored by Sechenov University
Historically, Russian science has a strong systematic foundation and a unique potential focused on breakthrough discoveries, development of leading technologies, and implementation of innovative products that ensure preservation and improvement of people’s lives. Today, however, the volume of scientific results exceeds that of solutions introduced into practice: research and development do not always reflect the current needs of the public and are not always in demand by the healthcare system. Unfavourable factors for the growth of the Russian medical science include inter-departmental disconnectedness and low innovative activity of business. Thus, results of scientific achievements are poorly integrated into healthcare and a situation of lost opportunities for use of new drugs and technologies is created in society. Building a favourable environment for medical science is a strategic task of the national government policy growth. It starts with systematic analysis of practical healthcare needs, an expert evaluation of research and development, and goes all the way to building strategies for financing and introducing scientific achievements into the healthcare system. The year 2020 has given a special standing to international cooperation in development of medical science, setting the course toward sharing experience and looking for new growth paths, and that means restoring the status quo of Russian science among the leading global scientific countries.
● How well does the Strategy for the Development of Medical Science in the Russian Federation until 2025 correspond to the goals of strengthening the industry’s positions?
● Solution of which problems will promote the advancement of the level of fundamental and applicable scientific research and growth of the scientific human capital?
● How can innovative activity of Russian business be increased and the share of R&D in the national pharma industry enlarged?
● What state strategies should promote expedited introduction of scientific research results into practical healthcare?
● How can the process of integrating Russian medical science into the global science community be expedited?
Evelina Zakamskaya — Editor-in-Chief, Doctor Channel; Anchor, Russia 24
Petr Glybochko — Rector, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Andrey Kaprin — Director, Federal State Budgetary Institution National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation
Alla Samoylova — Head, Federal Service for Surveillance in Healthcare (Roszdravnadzor)
Veronika Skvortsova — Head, Federal Medical-Biological Agency of the Russian Federation
Dmitry Kudlay — General Director, Generium
Simon Matskeplishvili — Deputy Scientific Director, Lomonosov Moscow State University Clinic; Member of the Board, Russian Society of Cardiology
Vadim Merkulov — Deputy Director General for Drug Expertise, Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation
● How well does the Strategy for the Development of Medical Science in the Russian Federation until 2025 correspond to the goals of strengthening the industry’s positions?
● Solution of which problems will promote the advancement of the level of fundamental and applicable scientific research and growth of the scientific human capital?
● How can innovative activity of Russian business be increased and the share of R&D in the national pharma industry enlarged?
● What state strategies should promote expedited introduction of scientific research results into practical healthcare?
● How can the process of integrating Russian medical science into the global science community be expedited?
Moderator:
Evelina Zakamskaya — Editor-in-Chief, Doctor Channel; Anchor, Russia 24
Evelina Zakamskaya was born on November 17, 1977, in Baku, and graduated from the Faculty of Philology at Tver State University. She is a presenter for Radio Mayak and for Mir, a television and radio company. Since 2006, she has been an anchor for television channel Russia 24. She writes and presents Mnenie (Opinion), a talk show covering social and political issues, and Idei, menyayushchie mir (World-Changing Ideas), a series of popular science programmes. Evelina Zakamskaya moderates Russia 24 sessions at major international forums. Since 2017 - Editor-in-Chief, Doctor Channel. She is married with two daughters.
Panellists:
Petr Glybochko — Rector, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Andrey Kaprin — Director, Federal State Budgetary Institution National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation
· Doctor of Medical Sciences, Professor, Academician of RAS, Honored Doctor of the Russian Federation.
· Director General of the National Medical Research Radiological Centre (NMRRC) of Ministry of Health of the Russian Federation, Director of the P.A. Herzen Moscow Cancer Research Institute, a branch of NMRRC.
· He is one of the leading specialists in the Russian Federation in the field of diagnosis and treatment of oncological diseases. Throughout the scientific and therapeutic activity, Andrey Kaprin conducts a purposeful development of modern methods of surgical and combined treatment of kidney, bladder, prostate and other localizations.
· Since 2014, Andrey Kaprin is heaing the first Russian scientific medical cluster in the field of oncology - the Federal State Budgetary Institution "National Medical Research Radiological Centre" of Ministry of Health of the Russian Federation, which was established on the basis of three leading medical centers - P. Herzen, A.Tsyb MRRC, and N. Lopatkin Research Institute of Urology and Interventional Radiology.
· At present, being the head of the NMRRC of Ministry of Health of the Russian Federation, being an academician of the Russian Academy of Sciences in oncoradiology, he supervises the development of nuclear medicine, radiology and radiotherapy in our country. He has taken charge of most complex and promising areas in the industry: the technical re-equipment of the radiation therapy departments of the regions, the creation of a program and a center for the development of contact methods of irradiation, the introduction and expansion of the first national medical proton center in the country, the introduction of modern methods of training specialists in radiology and radiotherapy, iIncluding telecommunication training and master classes in the regions, many of which are conducted by himself.
· Every year Andrey Kaprin performs over 300 complex surgical interventions for various oncological diseases.
· He has trained more than 300 doctors, including residents and graduate students. Under his leadership, 27 dissertations for the degree of candidate of medical sciences and 9 doctoral dissertations were prepared and successfully defended. The result of many years of hard work was the publication of more than 700 printed scientific works.
· Director General of the National Medical Research Radiological Centre (NMRRC) of Ministry of Health of the Russian Federation, Director of the P.A. Herzen Moscow Cancer Research Institute, a branch of NMRRC.
· He is one of the leading specialists in the Russian Federation in the field of diagnosis and treatment of oncological diseases. Throughout the scientific and therapeutic activity, Andrey Kaprin conducts a purposeful development of modern methods of surgical and combined treatment of kidney, bladder, prostate and other localizations.
· Since 2014, Andrey Kaprin is heaing the first Russian scientific medical cluster in the field of oncology - the Federal State Budgetary Institution "National Medical Research Radiological Centre" of Ministry of Health of the Russian Federation, which was established on the basis of three leading medical centers - P. Herzen, A.Tsyb MRRC, and N. Lopatkin Research Institute of Urology and Interventional Radiology.
· At present, being the head of the NMRRC of Ministry of Health of the Russian Federation, being an academician of the Russian Academy of Sciences in oncoradiology, he supervises the development of nuclear medicine, radiology and radiotherapy in our country. He has taken charge of most complex and promising areas in the industry: the technical re-equipment of the radiation therapy departments of the regions, the creation of a program and a center for the development of contact methods of irradiation, the introduction and expansion of the first national medical proton center in the country, the introduction of modern methods of training specialists in radiology and radiotherapy, iIncluding telecommunication training and master classes in the regions, many of which are conducted by himself.
· Every year Andrey Kaprin performs over 300 complex surgical interventions for various oncological diseases.
· He has trained more than 300 doctors, including residents and graduate students. Under his leadership, 27 dissertations for the degree of candidate of medical sciences and 9 doctoral dissertations were prepared and successfully defended. The result of many years of hard work was the publication of more than 700 printed scientific works.
Vladimir Lazar — Chief Scientific and Operating Officer Worldwide Innovative Network Association - WIN Consortium
(online)
Alla Samoylova — Head, Federal Service for Surveillance in Healthcare (Roszdravnadzor)
Born in Cheboksary.
1990: Graduated from the Chuvash State University named after I. N. Ulyanov with a degree in medicine.
2002: Awarded with the badge “Excellent Worker of Public Health”.
2007: Honored doctor of the Chuvash Republic.
2010: Doctor of Science in medicine.
2012: Professor of obstetrics and gynecology.
1987-1990 – nurse, obstetrician-gynecologist at the industrial hospitals in Cheboksary.
1990-1993 – Full-time postgraduate study at Chuvash State University.
1993-1994 - Assistant at the Obstetrics and Gynecology Department of the Chuvash State University.
1994-2012 – Chief Doctor of the Presidential Perinatal Center of the Ministry of Health and social development of the Chuvash Republic.
2010-2017 – Head of the Department of Obstetrics and Gynecology named after G. M. Vorontsova, of the Chuvash State University.
2012-2015 – Deputy Chair at the Cabinet of Ministers of the Chuvash Republic - Minister of Health and Social Development of the Chuvash Republic.
2015-2017 – Minister of Health of the Chuvash Republic.
2018-2019 – Adviser to the Head of the Federal Service for Surveillance in Healthcare.
2019-2020 – Head of the Department of State Control of Implementation of State Healthcare Programs, the Federal Service for Surveillance in Healthcare.
2020 – Director of the Project Activities Department, the Ministry of Health of the Russian Federation.
Since April 10, 2020 - Head of the Federal Service for Surveillance in Healthcare.
1990: Graduated from the Chuvash State University named after I. N. Ulyanov with a degree in medicine.
2002: Awarded with the badge “Excellent Worker of Public Health”.
2007: Honored doctor of the Chuvash Republic.
2010: Doctor of Science in medicine.
2012: Professor of obstetrics and gynecology.
1987-1990 – nurse, obstetrician-gynecologist at the industrial hospitals in Cheboksary.
1990-1993 – Full-time postgraduate study at Chuvash State University.
1993-1994 - Assistant at the Obstetrics and Gynecology Department of the Chuvash State University.
1994-2012 – Chief Doctor of the Presidential Perinatal Center of the Ministry of Health and social development of the Chuvash Republic.
2010-2017 – Head of the Department of Obstetrics and Gynecology named after G. M. Vorontsova, of the Chuvash State University.
2012-2015 – Deputy Chair at the Cabinet of Ministers of the Chuvash Republic - Minister of Health and Social Development of the Chuvash Republic.
2015-2017 – Minister of Health of the Chuvash Republic.
2018-2019 – Adviser to the Head of the Federal Service for Surveillance in Healthcare.
2019-2020 – Head of the Department of State Control of Implementation of State Healthcare Programs, the Federal Service for Surveillance in Healthcare.
2020 – Director of the Project Activities Department, the Ministry of Health of the Russian Federation.
Since April 10, 2020 - Head of the Federal Service for Surveillance in Healthcare.
Tatyana Semenova — Deputy Minister of Health of the Russian Federation
Veronika Skvortsova — Head, Federal Medical-Biological Agency of the Russian Federation
Veronika Skvortsova was born in Moscow on November 1, 1960.
She graduated from the 2nd Pirogov Moscow State Medical Institute in 1983 and completed a Postgraduate Clinical Residency Programme and an Advanced Postgraduate Programme specializing in neuropathology. In 1994, she qualified as a higher category neurologist.
After graduating, she worked for the 2nd Moscow State Medical Institute (the Russian State Medical University since 1991) for 25 years.
Veronika Skvortsova became head of one of Russia’s first neurology emergency services at Moscow’s 1st municipal hospital established on the basis of the neurology clinic of the 2nd Moscow State Medical Institute in 1989.
In 1989–1995, she served as assistant and, in 1995–1997, as assistant professor at the Neuropathology Department of the Russian State Medical University.
She became Head of the Fundamental and Clinical Neurology and Neurosurgery Department in 1997.
Veronika Skvortsova was appointed Director of the Russian Stroke Research Institute in 2005.
She was Deputy Minister of Healthcare and Social Development from 2008 to 2012.
Veronika Skvortsova was appointed Minister of Healthcare by Presidential Executive Order No. 650 of May 21, 2012.
She is vice-president and co-founder of the National Stroke Association, director of the World Stroke Organization and secretary general of the European Stroke Council.
She is a Doctor of Medicine, Professor, and Corresponding Member of the Russian Academy of Medical Sciences.
Veronika Skvortsova is an Honored Scientist of the Russian Federation.
She has been awarded an Order of Honour and won the Pirogov Prize and Moscow Government Prize in Medicine.
She is the author of more than 400 research papers and holds seven patents for her inventions.
She graduated from the 2nd Pirogov Moscow State Medical Institute in 1983 and completed a Postgraduate Clinical Residency Programme and an Advanced Postgraduate Programme specializing in neuropathology. In 1994, she qualified as a higher category neurologist.
After graduating, she worked for the 2nd Moscow State Medical Institute (the Russian State Medical University since 1991) for 25 years.
Veronika Skvortsova became head of one of Russia’s first neurology emergency services at Moscow’s 1st municipal hospital established on the basis of the neurology clinic of the 2nd Moscow State Medical Institute in 1989.
In 1989–1995, she served as assistant and, in 1995–1997, as assistant professor at the Neuropathology Department of the Russian State Medical University.
She became Head of the Fundamental and Clinical Neurology and Neurosurgery Department in 1997.
Veronika Skvortsova was appointed Director of the Russian Stroke Research Institute in 2005.
She was Deputy Minister of Healthcare and Social Development from 2008 to 2012.
Veronika Skvortsova was appointed Minister of Healthcare by Presidential Executive Order No. 650 of May 21, 2012.
She is vice-president and co-founder of the National Stroke Association, director of the World Stroke Organization and secretary general of the European Stroke Council.
She is a Doctor of Medicine, Professor, and Corresponding Member of the Russian Academy of Medical Sciences.
Veronika Skvortsova is an Honored Scientist of the Russian Federation.
She has been awarded an Order of Honour and won the Pirogov Prize and Moscow Government Prize in Medicine.
She is the author of more than 400 research papers and holds seven patents for her inventions.
Shahrokh Shariat — Chairman, Department of Urology of the Medical University of Vienna
(online)
Front row participants:
Dmitry Kudlay — General Director, Generium
MD, professor
Academic background
University: Medical University, Novosibirsk
Department and Qualification: General medicine, doctor
Professional background
1996 - 1999 – Director, the hospital of the Ministry of Internal Affairs, Novosibirsk
2000 - 2004 – Managing positions in Marketing & Promotion, Russian pharmaceutical industry
2004 - 2013 – Deputy General Director (Marketing & Promotion), PHARMSTANDARD (the largest Russian pharmaceutical company)
2013 - present – General director, GENERIUM
Membership and Awards
• Member of the Government Subcommittee on the Circulation of Medicines
• Member of the working group on the Eurasian Economic Commission drug market, MoH
• Member of the Expert Council for the Development of Pharmaceutical and Medical Industry, Ministry of Industry and Trade
• Member of European Respiratory Society
• Winner of the Russian Federation Government Award
Dmitry Kudlay is the author of more than 70 scientific articles in peer-reviewed Russian and foreign publications.
Academic background
University: Medical University, Novosibirsk
Department and Qualification: General medicine, doctor
Professional background
1996 - 1999 – Director, the hospital of the Ministry of Internal Affairs, Novosibirsk
2000 - 2004 – Managing positions in Marketing & Promotion, Russian pharmaceutical industry
2004 - 2013 – Deputy General Director (Marketing & Promotion), PHARMSTANDARD (the largest Russian pharmaceutical company)
2013 - present – General director, GENERIUM
Membership and Awards
• Member of the Government Subcommittee on the Circulation of Medicines
• Member of the working group on the Eurasian Economic Commission drug market, MoH
• Member of the Expert Council for the Development of Pharmaceutical and Medical Industry, Ministry of Industry and Trade
• Member of European Respiratory Society
• Winner of the Russian Federation Government Award
Dmitry Kudlay is the author of more than 70 scientific articles in peer-reviewed Russian and foreign publications.
Simon Matskeplishvili — Deputy Scientific Director, Lomonosov Moscow State University Clinic; Member of the Board, Russian Society of Cardiology
Simon Matskeplishvili, MD, PhD, FESC, FACC, is a Professor of Cardiology and a Chief Scientific and Clinical Researcher at the Bakoulev Scientific Center for Cardiovascular Surgery in Moscow and an adjunct professor of life sciences at the Moscow Institute of Physics and Technology.
He also serves as a member of the Education, Certification and Accreditation, European Communities Committees of the European Association of Cardiovascular Imaging.
He graduated with honors from the Moscow Medical Academy in 1994 and had his postgraduate training and fellowship in cardiology at the Clinico-Diagnostic Department of the Bakoulev Center.
In 1997-1998 he received a degree of the International Master in Cardiology from the Institute of Clinical Physiology of the National Research Council of Italy in Pisa.
Simon Matskeplishvili is a Fellow of the European Society of Cardiology and a Fellow of the American College of Cardiology. He has received numerous honours and awards, both in Russia and internationally, including the European Cardiology award in 2001. He is a founder and a Chairman of the echocardiography section of the Russian society of cardiology. In 2007 he became a full professor of cardiology.
For the development of new non-invasive method of intracardiac blood flow evaluation in 2012 he was awarded a State Prize of the Government of Russian Federation in science and technology.
In 2013 he was a captain of the Russian team to win an ESC Cardiology Quiz “Primus inter pares” at the European Congress of Cardiology in Amsterdam.
In 2012 Professor Simon Matskeplishvili had organized and implemented the Educational Program for cardiologists and internal medicine physicians in Moscow. He also conducts an English-language elective course “Amazing Cardiology” in cardiology, cardiac surgery and cardiovascular imaging at the Faculty of Medicine of the Lomonosov Moscow State University.
The Board of the European Society of Cardiology has appointed Simon Matskeplishvili as the Coordinator of the Congress Programme Committee of the European Society of Cardiology Congress 2015-2016.
He also serves as a member of the Education, Certification and Accreditation, European Communities Committees of the European Association of Cardiovascular Imaging.
He graduated with honors from the Moscow Medical Academy in 1994 and had his postgraduate training and fellowship in cardiology at the Clinico-Diagnostic Department of the Bakoulev Center.
In 1997-1998 he received a degree of the International Master in Cardiology from the Institute of Clinical Physiology of the National Research Council of Italy in Pisa.
Simon Matskeplishvili is a Fellow of the European Society of Cardiology and a Fellow of the American College of Cardiology. He has received numerous honours and awards, both in Russia and internationally, including the European Cardiology award in 2001. He is a founder and a Chairman of the echocardiography section of the Russian society of cardiology. In 2007 he became a full professor of cardiology.
For the development of new non-invasive method of intracardiac blood flow evaluation in 2012 he was awarded a State Prize of the Government of Russian Federation in science and technology.
In 2013 he was a captain of the Russian team to win an ESC Cardiology Quiz “Primus inter pares” at the European Congress of Cardiology in Amsterdam.
In 2012 Professor Simon Matskeplishvili had organized and implemented the Educational Program for cardiologists and internal medicine physicians in Moscow. He also conducts an English-language elective course “Amazing Cardiology” in cardiology, cardiac surgery and cardiovascular imaging at the Faculty of Medicine of the Lomonosov Moscow State University.
The Board of the European Society of Cardiology has appointed Simon Matskeplishvili as the Coordinator of the Congress Programme Committee of the European Society of Cardiology Congress 2015-2016.
Vadim Merkulov — Deputy Director General for Drug Expertise, Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation
Doctor of Medical Sciences, Professor of Molecular Biology
Deputy Director General for Drug Expertise, Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation
Born in 1970 in Bryansk. In 1994, Dr. Merkulov graduated from Smolensk State Medical Institute. After graduation, he served in the Russian Armed Forces.
Scope of scientific interest:
Expert study of pharmaceuticals, molecular biology; molecular diagnostics of viral infections; research of antiviral agents using genetic engineering techniques; experimental immunology. Dr. Merkulov is a developer of diagnostic products for detection of several causative agents of particularly dangerous viral infections, as well as routine treatment for influenza. He authored more than 100 scientific papers and holds 9 patents.
Career:
• Dr. Merkulov held research positions while serving in the Russian Armed Forces.
• Since 2008: part-time Professor of the Department of Medical Nanobiotechnology at the Pirogov Russian National Research Medical University.
• 2010–2015: First Deputy Director General at the Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation.
• Since 2015: Deputy Director General for Drug Expertise at the Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation.
Deputy Director General for Drug Expertise, Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation
Born in 1970 in Bryansk. In 1994, Dr. Merkulov graduated from Smolensk State Medical Institute. After graduation, he served in the Russian Armed Forces.
Scope of scientific interest:
Expert study of pharmaceuticals, molecular biology; molecular diagnostics of viral infections; research of antiviral agents using genetic engineering techniques; experimental immunology. Dr. Merkulov is a developer of diagnostic products for detection of several causative agents of particularly dangerous viral infections, as well as routine treatment for influenza. He authored more than 100 scientific papers and holds 9 patents.
Career:
• Dr. Merkulov held research positions while serving in the Russian Armed Forces.
• Since 2008: part-time Professor of the Department of Medical Nanobiotechnology at the Pirogov Russian National Research Medical University.
• 2010–2015: First Deputy Director General at the Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation.
• Since 2015: Deputy Director General for Drug Expertise at the Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation.